1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anemia Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Supplements 1.2.3 Antibiotics 1.2.4 Immunosuppressant 1.2.5 Bone Marrow Stimulants 1.2.6 Corticosteroids 1.2.7 Gene Therapy 1.2.8 Iron Chelating Agents 1.3 Market by Application 1.3.1 Global Anemia Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Iron deficiency anemia 1.3.3 Thalassemia 1.3.4 Aplastic anemia 1.3.5 Hemolytic anemia 1.3.6 Sickle cell anemia 1.3.7 Pernicious anemia 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anemia Treatment Drugs Market Perspective (2016-2027) 2.2 Anemia Treatment Drugs Growth Trends by Regions 2.2.1 Anemia Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Anemia Treatment Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Anemia Treatment Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Anemia Treatment Drugs Industry Dynamic 2.3.1 Anemia Treatment Drugs Market Trends 2.3.2 Anemia Treatment Drugs Market Drivers 2.3.3 Anemia Treatment Drugs Market Challenges 2.3.4 Anemia Treatment Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anemia Treatment Drugs Players by Revenue 3.1.1 Global Top Anemia Treatment Drugs Players by Revenue (2016-2021) 3.1.2 Global Anemia Treatment Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Anemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Anemia Treatment Drugs Revenue 3.4 Global Anemia Treatment Drugs Market Concentration Ratio 3.4.1 Global Anemia Treatment Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anemia Treatment Drugs Revenue in 2020 3.5 Anemia Treatment Drugs Key Players Head office and Area Served 3.6 Key Players Anemia Treatment Drugs Product Solution and Service 3.7 Date of Enter into Anemia Treatment Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anemia Treatment Drugs Breakdown Data by Type 4.1 Global Anemia Treatment Drugs Historic Market Size by Type (2016-2021) 4.2 Global Anemia Treatment Drugs Forecasted Market Size by Type (2022-2027) 5 Anemia Treatment Drugs Breakdown Data by Application 5.1 Global Anemia Treatment Drugs Historic Market Size by Application (2016-2021) 5.2 Global Anemia Treatment Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Anemia Treatment Drugs Market Size (2016-2027) 6.2 North America Anemia Treatment Drugs Market Size by Type 6.2.1 North America Anemia Treatment Drugs Market Size by Type (2016-2021) 6.2.2 North America Anemia Treatment Drugs Market Size by Type (2022-2027) 6.2.3 North America Anemia Treatment Drugs Market Size by Type (2016-2027) 6.3 North America Anemia Treatment Drugs Market Size by Application 6.3.1 North America Anemia Treatment Drugs Market Size by Application (2016-2021) 6.3.2 North America Anemia Treatment Drugs Market Size by Application (2022-2027) 6.3.3 North America Anemia Treatment Drugs Market Size by Application (2016-2027) 6.4 North America Anemia Treatment Drugs Market Size by Country 6.4.1 North America Anemia Treatment Drugs Market Size by Country (2016-2021) 6.4.2 North America Anemia Treatment Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Anemia Treatment Drugs Market Size (2016-2027) 7.2 Europe Anemia Treatment Drugs Market Size by Type 7.2.1 Europe Anemia Treatment Drugs Market Size by Type (2016-2021) 7.2.2 Europe Anemia Treatment Drugs Market Size by Type (2022-2027) 7.2.3 Europe Anemia Treatment Drugs Market Size by Type (2016-2027) 7.3 Europe Anemia Treatment Drugs Market Size by Application 7.3.1 Europe Anemia Treatment Drugs Market Size by Application (2016-2021) 7.3.2 Europe Anemia Treatment Drugs Market Size by Application (2022-2027) 7.3.3 Europe Anemia Treatment Drugs Market Size by Application (2016-2027) 7.4 Europe Anemia Treatment Drugs Market Size by Country 7.4.1 Europe Anemia Treatment Drugs Market Size by Country (2016-2021) 7.4.2 Europe Anemia Treatment Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Anemia Treatment Drugs Market Size (2016-2027) 8.2 Asia-Pacific Anemia Treatment Drugs Market Size by Type 8.2.1 Asia-Pacific Anemia Treatment Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Anemia Treatment Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Anemia Treatment Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Anemia Treatment Drugs Market Size by Application 8.3.1 Asia-Pacific Anemia Treatment Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Anemia Treatment Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Anemia Treatment Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Anemia Treatment Drugs Market Size by Region 8.4.1 Asia-Pacific Anemia Treatment Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Anemia Treatment Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anemia Treatment Drugs Market Size (2016-2027) 9.2 Latin America Anemia Treatment Drugs Market Size by Type 9.2.1 Latin America Anemia Treatment Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Anemia Treatment Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Anemia Treatment Drugs Market Size by Type (2016-2027) 9.3 Latin America Anemia Treatment Drugs Market Size by Application 9.3.1 Latin America Anemia Treatment Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Anemia Treatment Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Anemia Treatment Drugs Market Size by Application (2016-2027) 9.4 Latin America Anemia Treatment Drugs Market Size by Country 9.4.1 Latin America Anemia Treatment Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Anemia Treatment Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anemia Treatment Drugs Market Size (2016-2027) 10.2 Middle East & Africa Anemia Treatment Drugs Market Size by Type 10.2.1 Middle East & Africa Anemia Treatment Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Anemia Treatment Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Anemia Treatment Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Anemia Treatment Drugs Market Size by Application 10.3.1 Middle East & Africa Anemia Treatment Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Anemia Treatment Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Anemia Treatment Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Anemia Treatment Drugs Market Size by Country 10.4.1 Middle East & Africa Anemia Treatment Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Anemia Treatment Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer, Inc. 11.1.1 Pfizer, Inc. Company Details 11.1.2 Pfizer, Inc. Business Overview 11.1.3 Pfizer, Inc. Anemia Treatment Drugs Introduction 11.1.4 Pfizer, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021) 11.1.5 Pfizer, Inc. Recent Development 11.2 Amgen, Inc. 11.2.1 Amgen, Inc. Company Details 11.2.2 Amgen, Inc. Business Overview 11.2.3 Amgen, Inc. Anemia Treatment Drugs Introduction 11.2.4 Amgen, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021) 11.2.5 Amgen, Inc. Recent Development 11.3 Hoffmann-La Roche Ltd. 11.3.1 Hoffmann-La Roche Ltd. Company Details 11.3.2 Hoffmann-La Roche Ltd. Business Overview 11.3.3 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Introduction 11.3.4 Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business (2016-2021) 11.3.5 Hoffmann-La Roche Ltd. Recent Development 11.4 Merck Sharp & Dohme Corp. 11.4.1 Merck Sharp & Dohme Corp. Company Details 11.4.2 Merck Sharp & Dohme Corp. Business Overview 11.4.3 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Introduction 11.4.4 Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business (2016-2021) 11.4.5 Merck Sharp & Dohme Corp. Recent Development 11.5 Novartis AG 11.5.1 Novartis AG Company Details 11.5.2 Novartis AG Business Overview 11.5.3 Novartis AG Anemia Treatment Drugs Introduction 11.5.4 Novartis AG Revenue in Anemia Treatment Drugs Business (2016-2021) 11.5.5 Novartis AG Recent Development 11.6 Janssen Pharmaceutical 11.6.1 Janssen Pharmaceutical Company Details 11.6.2 Janssen Pharmaceutical Business Overview 11.6.3 Janssen Pharmaceutical Anemia Treatment Drugs Introduction 11.6.4 Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business (2016-2021) 11.6.5 Janssen Pharmaceutical Recent Development 11.7 Bayer AG 11.7.1 Bayer AG Company Details 11.7.2 Bayer AG Business Overview 11.7.3 Bayer AG Anemia Treatment Drugs Introduction 11.7.4 Bayer AG Revenue in Anemia Treatment Drugs Business (2016-2021) 11.7.5 Bayer AG Recent Development 11.8 AMAG Pharmaceuticals 11.8.1 AMAG Pharmaceuticals Company Details 11.8.2 AMAG Pharmaceuticals Business Overview 11.8.3 AMAG Pharmaceuticals Anemia Treatment Drugs Introduction 11.8.4 AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business (2016-2021) 11.8.5 AMAG Pharmaceuticals Recent Development 11.9 GlaxoSmithKline plc 11.9.1 GlaxoSmithKline plc Company Details 11.9.2 GlaxoSmithKline plc Business Overview 11.9.3 GlaxoSmithKline plc Anemia Treatment Drugs Introduction 11.9.4 GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business (2016-2021) 11.9.5 GlaxoSmithKline plc Recent Development 11.10 Akebia Therapeutics 11.10.1 Akebia Therapeutics Company Details 11.10.2 Akebia Therapeutics Business Overview 11.10.3 Akebia Therapeutics Anemia Treatment Drugs Introduction 11.10.4 Akebia Therapeutics Revenue in Anemia Treatment Drugs Business (2016-2021) 11.10.5 Akebia Therapeutics Recent Development 11.11 Vifor Pharma Management, Ltd. 11.11.1 Vifor Pharma Management, Ltd. Company Details 11.11.2 Vifor Pharma Management, Ltd. Business Overview 11.11.3 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Introduction 11.11.4 Vifor Pharma Management, Ltd. Revenue in Anemia Treatment Drugs Business (2016-2021) 11.11.5 Vifor Pharma Management, Ltd. Recent Development 11.12 FibroGen, Inc. 11.12.1 FibroGen, Inc. Company Details 11.12.2 FibroGen, Inc. Business Overview 11.12.3 FibroGen, Inc. Anemia Treatment Drugs Introduction 11.12.4 FibroGen, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021) 11.12.5 FibroGen, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Anemia Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Supplements Table 3. Key Players of Antibiotics Table 4. Key Players of Immunosuppressant Table 5. Key Players of Bone Marrow Stimulants Table 6. Key Players of Corticosteroids Table 7. Key Players of Gene Therapy Table 8. Key Players of Iron Chelating Agents Table 9. Global Anemia Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Anemia Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Anemia Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Anemia Treatment Drugs Market Share by Regions (2016-2021) Table 13. Global Anemia Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Anemia Treatment Drugs Market Share by Regions (2022-2027) Table 15. Anemia Treatment Drugs Market Trends Table 16. Anemia Treatment Drugs Market Drivers Table 17. Anemia Treatment Drugs Market Challenges Table 18. Anemia Treatment Drugs Market Restraints Table 19. Global Anemia Treatment Drugs Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Anemia Treatment Drugs Market Share by Players (2016-2021) Table 21. Global Top Anemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Treatment Drugs as of 2020) Table 22. Ranking of Global Top Anemia Treatment Drugs Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Anemia Treatment Drugs Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Anemia Treatment Drugs Product Solution and Service Table 26. Date of Enter into Anemia Treatment Drugs Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 29. Global Anemia Treatment Drugs Revenue Market Share by Type (2016-2021) Table 30. Global Anemia Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Anemia Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Anemia Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Anemia Treatment Drugs Revenue Market Share by Application (2016-2021) Table 34. Global Anemia Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Anemia Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 37. North America Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 39. North America Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Anemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Anemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Anemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Anemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Anemia Treatment Drugs Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Anemia Treatment Drugs Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Anemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Anemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Anemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Anemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 66. Pfizer, Inc. Company Details Table 67. Pfizer, Inc. Business Overview Table 68. Pfizer, Inc. Anemia Treatment Drugs Product Table 69. Pfizer, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 70. Pfizer, Inc. Recent Development Table 71. Amgen, Inc. Company Details Table 72. Amgen, Inc. Business Overview Table 73. Amgen, Inc. Anemia Treatment Drugs Product Table 74. Amgen, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 75. Amgen, Inc. Recent Development Table 76. Hoffmann-La Roche Ltd. Company Details Table 77. Hoffmann-La Roche Ltd. Business Overview Table 78. Hoffmann-La Roche Ltd. Anemia Treatment Drugs Product Table 79. Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 80. Hoffmann-La Roche Ltd. Recent Development Table 81. Merck Sharp & Dohme Corp. Company Details Table 82. Merck Sharp & Dohme Corp. Business Overview Table 83. Merck Sharp & Dohme Corp. Anemia Treatment Drugs Product Table 84. Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 85. Merck Sharp & Dohme Corp. Recent Development Table 86. Novartis AG Company Details Table 87. Novartis AG Business Overview Table 88. Novartis AG Anemia Treatment Drugs Product Table 89. Novartis AG Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 90. Novartis AG Recent Development Table 91. Janssen Pharmaceutical Company Details Table 92. Janssen Pharmaceutical Business Overview Table 93. Janssen Pharmaceutical Anemia Treatment Drugs Product Table 94. Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 95. Janssen Pharmaceutical Recent Development Table 96. Bayer AG Company Details Table 97. Bayer AG Business Overview Table 98. Bayer AG Anemia Treatment Drugs Product Table 99. Bayer AG Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 100. Bayer AG Recent Development Table 101. AMAG Pharmaceuticals Company Details Table 102. AMAG Pharmaceuticals Business Overview Table 103. AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 104. AMAG Pharmaceuticals Recent Development Table 105. GlaxoSmithKline plc Company Details Table 106. GlaxoSmithKline plc Business Overview Table 107. GlaxoSmithKline plc Anemia Treatment Drugs Product Table 108. GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 109. GlaxoSmithKline plc Recent Development Table 110. Akebia Therapeutics Company Details Table 111. Akebia Therapeutics Business Overview Table 112. Akebia Therapeutics Anemia Treatment Drugs Product Table 113. Akebia Therapeutics Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 114. Akebia Therapeutics Recent Development Table 115. Vifor Pharma Management, Ltd. Company Details Table 116. Vifor Pharma Management, Ltd. Business Overview Table 117. Vifor Pharma Management, Ltd. Anemia Treatment Drugs Product Table 118. Vifor Pharma Management, Ltd. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 119. Vifor Pharma Management, Ltd. Recent Development Table 120. FibroGen, Inc. Company Details Table 121. FibroGen, Inc. Business Overview Table 122. FibroGen, Inc. Anemia Treatment Drugs Product Table 123. FibroGen, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million) Table 124. FibroGen, Inc. Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Anemia Treatment Drugs Market Share by Type: 2020 VS 2027 Figure 2. Supplements Features Figure 3. Antibiotics Features Figure 4. Immunosuppressant Features Figure 5. Bone Marrow Stimulants Features Figure 6. Corticosteroids Features Figure 7. Gene Therapy Features Figure 8. Iron Chelating Agents Features Figure 9. Global Anemia Treatment Drugs Market Share by Application: 2020 VS 2027 Figure 10. Iron deficiency anemia Case Studies Figure 11. Thalassemia Case Studies Figure 12. Aplastic anemia Case Studies Figure 13. Hemolytic anemia Case Studies Figure 14. Sickle cell anemia Case Studies Figure 15. Pernicious anemia Case Studies Figure 16. Anemia Treatment Drugs Report Years Considered Figure 17. Global Anemia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 18. Global Anemia Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 19. Global Anemia Treatment Drugs Market Share by Regions: 2020 VS 2027 Figure 20. Global Anemia Treatment Drugs Market Share by Regions (2022-2027) Figure 21. Global Anemia Treatment Drugs Market Share by Players in 2020 Figure 22. Global Top Anemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Treatment Drugs as of 2020 Figure 23. The Top 10 and 5 Players Market Share by Anemia Treatment Drugs Revenue in 2020 Figure 24. Global Anemia Treatment Drugs Revenue Market Share by Type (2016-2021) Figure 25. Global Anemia Treatment Drugs Revenue Market Share by Type (2022-2027) Figure 26. North America Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. North America Anemia Treatment Drugs Market Share by Type (2016-2027) Figure 28. North America Anemia Treatment Drugs Market Share by Application (2016-2027) Figure 29. North America Anemia Treatment Drugs Market Share by Country (2016-2027) Figure 30. United States Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Canada Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Europe Anemia Treatment Drugs Market Share by Type (2016-2027) Figure 34. Europe Anemia Treatment Drugs Market Share by Application (2016-2027) Figure 35. Europe Anemia Treatment Drugs Market Share by Country (2016-2027) Figure 36. Germany Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. France Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. U.K. Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Italy Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Russia Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Nordic Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Asia-Pacific Anemia Treatment Drugs Market Share by Type (2016-2027) Figure 44. Asia-Pacific Anemia Treatment Drugs Market Share by Application (2016-2027) Figure 45. Asia-Pacific Anemia Treatment Drugs Market Share by Region (2016-2027) Figure 46. China Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Japan Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. South Korea Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Southeast Asia Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. India Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Australia Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Latin America Anemia Treatment Drugs Market Share by Type (2016-2027) Figure 54. Latin America Anemia Treatment Drugs Market Share by Application (2016-2027) Figure 55. Latin America Anemia Treatment Drugs Market Share by Country (2016-2027) Figure 56. Mexico Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Brazil Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Middle East & Africa Anemia Treatment Drugs Market Share by Type (2016-2027) Figure 60. Middle East & Africa Anemia Treatment Drugs Market Share by Application (2016-2027) Figure 61. Middle East & Africa Anemia Treatment Drugs Market Share by Country (2016-2027) Figure 62. Turkey Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Saudi Arabia Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. UAE Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 65. Pfizer, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 66. Amgen, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 67. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 68. Merck Sharp & Dohme Corp. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 69. Novartis AG Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 70. Janssen Pharmaceutical Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 71. Bayer AG Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 72. AMAG Pharmaceuticals Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 73. GlaxoSmithKline plc Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 74. Akebia Therapeutics Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 75. Vifor Pharma Management, Ltd. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 76. FibroGen, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021) Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

Pfizer, Inc. Amgen, Inc. Hoffmann-La Roche Ltd. Merck Sharp & Dohme Corp. Novartis AG Janssen Pharmaceutical Bayer AG AMAG Pharmaceuticals GlaxoSmithKline plc Akebia Therapeutics Vifor Pharma Management, Ltd. FibroGen, Inc.